Recombinant antigens
Infection |
Antigen |
Catalog # |
Antigen description |
Price (USD for 1 mg) |
HIV |
HIV-1: p17-p24-p15 |
R-0111 |
Synthesized in E.coli cells mosaic recombinant protein recombinant protein, containing joint with β-galactosidase immunodominant fragment of gag HIV-1 gene product: full-size р24 protein and fragments of р17 and р15 proteins |
220 |
HIV-1: p24 |
R-0112 |
Synthesized in E.coli cells recombinant protein, containing full-size р24 protein HIV-1 |
||
HIV-1: gp120-gp41 |
R-0113 |
Synthesized in E.coli cells mosaic recombinant protein, containing joint with β-galactosidase immunodominant fragment of env HIV-1 gene product from fragmebts of gр120 and gp41 proteins |
||
HIV-: gp160 |
R-0114 |
Synthesized in E.coli cells recombinant protein, containing joint with β- galactosidase fragment immunodominant fragment of gp160 HIV-1 precursor protein |
||
HIV-1: gp120 |
R-0115 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunodominant fragment of gp120 HIV-1 protein |
||
HIV-1: gp41 |
R-0116 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunodominant fragment of gp41 HIV-1 protein |
||
HIV-1: pol |
R-0117 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase polypeptide of three immunodominant fragments of protein-product of pol HIV-1 |
||
HIV-1: nef |
R-0118 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase N-end fragment of nef HIV-1 gene |
||
HIV-1: vif |
R-0119 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase full-size analog of vif HIV-1 gene |
||
HIV-2: gp140 |
R-0121 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase polypeptide, включающий immunodominant fragments of envelope proteins gp105 and gp36 HIV-2 |
||
Hepatitis C virus |
HCV: Core-1b |
R-0211 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of core-antigen of HCV genotype 1b |
220 |
HCV: NS4-1b |
R-0212 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of protein NS4а of HCV genotype 1b |
||
HCV: NS4-2a |
R-0221 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of protein NS4 of HCV genotype 2а |
||
HCV: NS4-3a |
R-0231 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of protein NS4 of HCV genotype 3а |
||
HCV: Core-NS4-1b |
R-0213 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase polypeptide of immunoreactive fragments of proteins NS4а and core of HCV genotype 1b |
||
HCV: NS3-1b |
R-0214 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment protein NS3 of HCV genotype 1b |
||
HCV: NS3-NS4-1a |
R-0215 |
Synthesized in E.coli cells recombinant protein, containing immunoreactive fragments of proteins NS3 and NS4а of HCV genotype 1а |
||
Cytomegalovirus |
CMV: pp150 |
R-0511 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase fragment of phosphoprotein of pр150 (pUL32) tegument of cytomegalovirus |
220 |
CMV: pp65 |
R-0512 |
Synthesized in E.coli cells recombinant protein-analog of phosphoprotein pр65 tegument of cytomegalovirus |
||
CMV: gB |
R-0513 |
Synthesized in E.coli cells recombinant protein, containing fragment of immunodominant domain AD1 of glycoprotein gB of cytomegalovirus |
||
CMV: pp52 |
R-0514 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of DNA-binding protein pp52(UL44) of cytomegalovirus |
||
Herpes simplex virus |
HSV-1: UL42 |
R-0611 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of DNA-binding protein of herpes simplex virus type 1 (gene UL42) |
220 |
HSV-1: UL54 |
R-0612 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of DNA-binding protein of herpes simplex virus type 1 (gene UL54) |
||
HSV-2: UL39 |
R-0621 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of DNA-binding protein of herpes simplex virus type 2 (gene UL39) |
||
Syphilis |
T.pal: p15 |
R-0411 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of lipoprotein 15kD Treponema pallidum |
220 |
T.pal: p17 |
R-0412 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of lipoprotein 17kD Treponema pallidum |
||
T.pal: p47 |
R-0413 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of lipoprotein 47kD Treponema pallidum |
||
T.pal: TmpA |
R-0414 |
Synthesized in E.coli cells recombinant protein, containing joint with β-galactosidase immunoreactive fragment of lipoprotein TmpA Treponema pallidum |
||
Hepatitis E virus |
HEV: pORF2 |
R-1011 |
Synthesized in E.coli cells recombinant protein, containing immunoreactive fragment of protein pORF2 of hepatitis E virus |
220 |
HEV: pORF3 |
R-1012 |
Synthesized in E.coli cells recombinant protein, containing immunoreactive fragment of protein pORF3 of hepatitis E virus |
||
Human T-lymphotropic virus |
HTLV-1: p19 |
R-2111 |
Synthesized in E.coli cells recombinant protein, containing immunodominant fragment protein of р19 HTLV-1 |
220 |
HTLV-1: gp46 |
R-2112 |
Synthesized in E.coli cells recombinant protein, containing immunodominant fragment of protein gp46 HTLV-1 |
||
HTLV-2: env |
R-2121 |
Synthesized in E.coli cells recombinant protein, containing immunodominant fragment of protein-product of gene env HTLV-2 |